throbber
MYLAN - EXHIBIT 1061
`Mylan Pharmaceuticals Inc. et al. v. Allergan, Inc.
`IPR2016-01127, -01128, -01129, -01130, -01131, & -01132
`
`

`

`
`
`Copyright © 1994 by Gilbert Smolin and Richard A. Theft
`
`ThirdEdfition
`
`Previous editions copyright © .1983, 1987 .by Gilbert Smolin
`and Richard A. Thofl;
`
`“
`
`All rights reserved. No part of this book may be reproduced in any
`form or by any electronic or mechanical means, including
`information Storage and retrieval systems, without permission in
`writing from'the publisher, except by a reviewer who may qiiote
`passages in a review.
`
`Library of Congress @ataloging—in-Eubfication Data
`
`The cornea : scientific foundations and clinical practice / edited by
`Gilbert Smolin, Richard A. Thoft.—3rd ed.
`p-
`cm.
`.
`Includes bibliographical references and index.
`ISBN Ell-3.1363627i)418
`A
`1. Cornea—Diseases.
`I. Smolin, Gilbert.
`Richard A.
`
`2. Cornea.
`
`II. Thoft,
`
`--=£DNLM: 1. Diseases.
`RE336.066 1994
`'
`'
`617.7'19—dc20
`DNLM/DLC
`
`for Library of Congress
`
`220 (38133 1994]
`'
`
`93-4460
`
`Printed in the United States of America
`EBM
`
`Editorial: Elizabeth Thompson, Robert J. Stuart
`Production Editor: Anne Holm
`
`Copyeditor: Mary Babcock
`indexer: Alexandra Nickeer
`
`ProductionSupervisorfDesigner: Michael A. Granger
`Cover Designer: Ethan Thomas
`
`
`
`
`
`

`

`
`
`
`
`
`
`Contents
`
`Contributing Authors
`Preface
`
`I. Basic Science
`1. Anatomy of the Conjunctiva,
`Cornea, and Limbus
`gene K. .Gépson
`2' ology
`Henry
`‘Ede’fiiauserfiDayle
`Gemski, and John L. Ubels
`3. Bioohemistry of the Cornea
`mend and
`HaSSeu
`John
`4; Morphology_and Pathologic
`Response of Gama} and
`Conjunctival Disease
`Kenneth R. Kenyon amt
`Henrique V. Chaves
`
`II. Clinical
`5. Bacterial Keratitis and
`
`,
`
`"
`
`'
`
`'
`
`Bacteriology
`Eileen M. Burd
`.
`Clinical Disease
`Gregory S. H. Og'éwa and
`Robert A. Hyndiuk
`6, Viral Keratiti's: and
`Conjunctivitis
`Wmlogy
`Paul R Kinchington
`Clinical Disease
`Herpetic Infections
`Deborah Pavan-Langston
`Adeva and Other
`'Nonherpetie Wrai‘Di-seases
`Jerold S. Gordon
`
`xi:
`xp
`
`3
`
`25
`
`47
`
`69
`
`115 "
`115 '
`.-
`125
`
`169
`169
`
`183
`
`$215
`
`3.
`
`7. Fungal Keratitis and‘
`Conjunctivitis
`Myeelegzy
`Denis M. O’Day and
`E11991“ M 3‘1”
`Clinical Dwease
`Rid-131‘?
`Forge? _
`- Female Keratms anti
`COIfjunéfifi'tiS
`quasltozogy
`.
`Mif’fiael 5:053“)
`Clinical Df‘sease
`Kirk Wilhelmus
`Keratitis and
`ConJWnths
`@‘medwtagy .
`REM S'IStephens
`01mm“; D5533?”
`John P: kadler .
`10. 811311th Infectious
`Diseases
`
`9-
`
`H. Bruce Ostler
`11. Basic Immunology of the
`_ Anterior Segment
`Gilbert Smolin
`12. Clinical Immunologic
`Diseases
`Ocular Allergy
`Peter C. Donshik and
`William H. Ehlers
`Rheumatoid Diseases
`Fuerst,
`David J. Schaninn,
`and Ronald E. Smith
`Non—rheumatoid Acquired
`Collagen Vascular Disease
`C. Stephen Foster
`Mooren’s Ulceration
`J.
`Derka Disease
`Barfly J. Mondino
`
`-
`229
`223
`
`239
`
`253
`
`262
`
`277.
`217
`
`282
`
`295
`
`305
`
`347
`347
`
`364
`
`385
`
`408
`
`414
`
`ix
`
`
`
`

`

`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`Physiolbgy of'the 'P‘ear
`David W. Lamberts
`Clinical Diseases of the
`Tear Film
`
`David
`
`Sjozgren’s Syndrome
`Khaiid F. Taliban
`
`Corneal Manifestations of
`Neurologic Diseases
`C. Stephen Foster
`Corneal Dystrophies and
`Degenerations
`Gilbert Smolin
`
`Congenital Anomalies of the
`Cornea anti Conjunctiva
`FredM. Wll's'on H-
`Metabolic Diseases
`Mitchell H. Friedlaender
`
`'Iiunors of the Conjunctiva
`am! Cornea
`Jerry A. Shiefls and
`Carol L. Shields
`
`Corneal and Conjnncfival
`Manifestations o'f'Die'tary
`Deficiencies
`Richard A. Thofl
`Corneal Trauma
`
`Physical Agents
`Robert G. Webster, Jr.
`
`439;
`
`457
`45'?
`
`477
`
`485
`
`535
`
`555
`
`519
`
`597
`
`605
`605-
`
`Contents
`
`Ckemieai
`James P. McCulley
`Endothelial Function
`Claes H. Dohlman
`
`22.
`
`Keratoplasty
`Lameliar and Penetrating
`S. Arthur Boruchofl' and
`
`Kemtopmsthesis
`James XL Aquavella
`Refractive Surgery
`Surgical Correction ofMyopia:
`Radial Kemtotomy and
`Excimer'Loser.
`_
`Photoreactive Keratectomy
`
`Roger F.“ Steinem
`Epikemtqnfiqkie- and“
`Keratomile‘usis
`David J. Schanzlin
`
`Correction ofAstigmatism
`Jay H. Krachmer
`Conjunctiva! and Limbo!
`Surgery for Corneal
`DiSeases
`
`26. Therapeutic Contact Lenses
`Mark J. Mannie
`
`Index
`
`51-?
`
`635
`
`645
`£545
`
`665
`
`673
`
`673
`
`696
`
`703
`
`709
`
`723
`
`739
`
` I3.
`
`21.
`
`
`
`

`

`
`
`
`
`
`
`Clinical Diseases of the
`Tear Film
`
`
`
`Keratoconjunctivitis Sicca
`
`David W. Lamberts
`
`This section considers four topics. The first is a
`rational method for dividing the dry eye syn-
`dromes into five categories. The second is the
`techniques available for diagnosing the dry eye,
`or Sicca, syndromes. The third is the currently or
`potentially available methods useful in treating
`these diseases. The complications of the dry eye
`syndromes are disoussed last. A dry eye or kera-
`toconjunctivitis sicca syndrome is said to exist
`when the quantity or quality of the precorneal
`tear film is insufficient to ensure the well-being
`of the ocular epithelial surface [39].
`
`Categories of Dry Eye Syndromes
`
`Dividing the dry eye syndromes into five varieties
`was originally suggested by Holly and Lemp [26].
`These divisions are based on specific deficiencies
`that may have been chosen somewhat arbitrarily;
`nevertheless, they have excellent clinical appli—
`cability The divisions are as follows: aqueous tear
`deficiency, mucin deficiency, lipid abnormalities,
`lid surfacing abnormalities, and epitheliopathies.
`
`Aqueous Tear Deficiency
`
`The aqueous layer forms the greatest bulk of the
`precorneal tear film. Aqueous tears are produced
`in the main lacri-mal glands, with a lesser contri-
`bution from the accessory glands of Wolfring and
`Krause. Aqueous deficiency is by far the most
`common of the dry eye syndromes. Various causes
`share responsibility for the aqueous deficiency
`syndromes (Table 14-1). In spite of their rather
`diverse origins, the clinical presentation of these
`diseases is similar. One entity, Sjogren’s syn—
`drome, is such an important disease it is dis-
`cussed separately in the second section of this
`chapter.
`
`457
`
`
`
`
`
`h'fihmlia‘uuwm‘a.-.“—m.
`
`
`."',-:A.aM‘thid-‘rv’!v
`:lb-‘l-.=
`355.];Mm
`
`
`2-15‘5:
`
`an
`
`

`

`458
`
`Part II Clinical Aspects
`
`Table 14-1. Causes of aqueous tear deficiency
`
`Table 14-2. Mucin deficiency diseases
`
`Congenital
`Riley-Day syndrome (familial dysautonomia) [57]
`Anhidrotic ectodermal dysplasia [59]
`Alacrima secondary to congenital absence of the
`lacrimal gland [7]
`Cri du chat syndrome [27]
`Absence of lacrimal nucleus [76]
`Congenital familial sensory neuropathy with
`anhidrosis [51]
`Adie’s syndrome [11]
`Multiple endocrine neopla‘sia [2]
`
`I
`Acquired
`Trauma to lacrirnal gland
`Surgical removal [62]
`Injury
`Radiation damage
`Inflammation of lacrimal gland
`Sjligren’s syndrome (see following section)
`Primary amyloidosis [65]
`Mumps
`Trachoma
`lnfiltrations
`Sarcoidosis [64]
`Lymphoma, leukemia [41]
`Amyloidosis
`Drugs
`Antihistamines [33]
`Thiabendazole [12]
`Antimuscarinics
`General anesthetics
`
`Neuroparalytic hyposecretiOn
`Brainstem lesions [6]
`Cerebellopontile angle and patrons bone lesions
`[52]
`Middle fossa floor lesions [76]
`Lesions of the sphenopalatine ganglion [76]
`
`Mucin Deficiency
`
`The mucin deficiency diseases are a more com-
`pact group of abnormalities than the aqueous de-
`ficiencies (Table 14-2). Mucin is produced primar-
`ily by the goblet cells of the conjunctiva. There is
`some evidence that at least a small amount of mu-
`
`cin is also produced by the main lacrimal gland
`[29]. With this in mind, it can be‘ said that those
`illnesses that damage the conjunctiva will result
`in mucin deficiency Whether or not the abnor-
`malities seen in these conditions are due to, or
`only associated with, the mucin deficiency is not
`yet clear, however.
`Kinoshita and colleagues [30] studied tear mu-
`cin levels in normal subjects and in patients with
`cicatricial pemphigoid. The results indicated that
`although there was a statistically significant de-
`
`Goblet cell dysfunction: vitamin A deficiency
`Goblet cell destruction
`Alkali burns
`
`Cicatricial pemphigoid
`SteVens-Johnson syndrome
`Trachoma
`
`Drug-induced
`Practolol [79]
`Echothiophate iodide [48]
`
`cream: in mucin levels in cicatricial pemphigoid, a
`substantial amount of mucin-like glycoprotein
`was still present in tears from these patients. In
`the pemphigoid patients, the goblet cell count was
`profoundly decreased, well out of proportion to
`the modest fall in mucin-like glycoprotein. The
`authors suggested that while moderate mucin de-
`ficiency may be associated with surface abnor-
`malities, such mucin deficiency may not be the
`only cause of the ocular surface problems. One
`might also conclude that the tear film is fragile
`enough to be susceptible to even slight falls in
`mucin level. Alternativer it is possible that mu-
`cin from different sources (lacrimal gland versus
`goblet cells) is qualitatively or functiOnally differ-
`ent and that a decrease in goblet cell mucin, while
`quantitatively small, may be important function-
`ally.
`
`Lipid Abnormalities
`
`Only in severe anhidrotic ectodermal dysplasia is
`there a true lipid deficiency. This is extremely
`rare and occurs when the meibomian glands are
`congenitally absent. A much more important as-
`pect of lipid abnormality involves changes found
`in the composition of meibomian secretions in
`various types of blepharitis. The bacteria that in-
`vade the meibomian glands secrete lipases that
`hydrolyze the normal lipids to produce various
`types of free fatty acids. These fatty acids are ex-
`tremely surface-active and are capable of ruptur-
`ing, on contact, an otherwise stable tear film.
`Whether these free fatty acids are directly toxic to
`the corneal epithelium or whether they only dam-
`age it via formation of dry spots is not known.
`Both mechanisms may play a role in the forma-
`tion of the superficial punctate staining com-
`monly seen in blepharitis.
`Gilbard and coworkers [19] closed the meibo-
`mian gland orifices in the right eyes of 11 rabbits
`by light cautery, and studied the changes for 20
`weeks. They found that tear film osmolarity was
`
`
`
`
`
`

`

`Chapter 14 Clinical Diseases of the Tear Film
`
`459
`
`increased throughout the observation period, con-
`junctival goblet cell density decreased, and cor-
`neal epithelial glycogen levels declined. They pos-
`tulated that the increase in tear film osmolarity
`was due to increased evaporation.
`
`Lid Surfacing Abnormalities
`
`.
`
`One of the most important functions of the lid is
`to resurface the eye with tears through constant
`blinking. In a blink, the eyelid sweeps the eye’s
`surface, brushing away exogenous contaminants
`as well as lipid-contaminated mucin strands.
`Fresh mucin is thereby distributed over the cor-
`neal and conjunctival surface. Any break in the
`integrity of the lid or its close apposition to the
`Ocular surface can produce areas of dryness. En-
`tities in this category are listed in Table 14-3. One
`of these items, dellen formation (from the German
`delle, meaning dent or depression), is unique and
`deserves separate comment. Dellen are areas of
`locally thinned cornea adjacent to limbal or con-
`junctiva] elevations. Dellen have been associated
`with muscle surgery, filtering blebs, and limbal
`and conjunctival tumors. The pathophysiology of
`dellen formation is shown in Figure 14-1. As the
`upper lid slides down over the limbal mass, it is
`unable to touch the adjacent “corneal valley.”
`There is a small area that is not resurfaced by the
`lid and does not receive a rejuvenated layer of mu-
`cin with each blink. This area is not able to sup-
`port a continuous tear film without the benefit of
`an adequate hydrophilic mucous layer. If allowed
`to persist, this area of dry cornea will dehydrate
`to the extent that a shallow crater will appear.
`These craters are dellen (Fig. 14-2). Fluorescein
`dye will pool in dellen, but the epithelium usually
`remains intact and will not stain. Most dellen will
`
`disappear if the eye is taped shut for 24 to 48
`hours. A similar pathophysiology explainsgthe 3
`
`Table 14-3. Lid surfacing abnormalities
`
`Lid problems
`Exposure keratitis
`. Entropion
`Ectropion
`Symblepharon _
`Large lid notches
`Lagophthalmos
`Keratinized lid margin
`Surface irregularities
`Dellen formation with limbal lesions
`3 and 9 o’clock stain in hard lens wearers
`
`Topical. anesthetic epitheliopathy
`
`
`
`Fig. 14-1. In the valley between any limbal mass and the
`angle of contact of the tear film with the cornea is a zone
`where the lid cannot wet the epithelium. It is here that a
`dellen forms. (Courtesy F. J. Holly, M.D., M.A. Lemp,
`\M.D., and C. H. Dohlman, MD.)
`
`
`
`Fig. 14-2. A dellen inside the limbus, adjacent to a swoln
`len and elevated coniunctival mass. (Courtesy David Don-
`aldson, MD.)
`
`an irregular or elevated area will predispose the
`
`and 9 o’clock staining syndrome commonly seen
`in hard contact lens wearers. In this case, the con-
`tact lens is the mass that interferes with the lid-
`
`globe integrity and thus prevents adequate wet-
`ting of the adjacent epithelium. This entity does
`not progress to the point of .stromal thinning,
`probably because of contact lens motion, but can
`be associated with superficial corneal vasculari-
`zation.
`
`Epitheliupathies
`
`An intact tear film, because it is very thin, is
`dependent on a smooth, uninterrupted epithelial
`surface. Any irregularity in the surface will cause
`an associated irregularity in the tear film. Such
`
`

`

`
`
`460
`
`Part II Clinical Aspects
`
`tear film to break up instantly at that spot. Since
`the actual cause of the corneal irregularity (e.g.,
`ulcer, erosion, scar) will usually be of primary
`concern, clinically this division of dry eye syn-
`dromes is the least important. It is included for
`the sake of completeness and to emphasize the
`point that the tear film is a fragile structure and
`subject to variances of the surface on which it
`rests.
`
`important reason for exploring skin problems
`during history taking is to discover entities that
`may mimic tear deficiency. A long list of skin dis-
`orders is associated with superficial punctate ker-
`atopathy and may present a picture that could be
`confused with sicca. Some of these-are seborrheic
`
`ichthyosis, and keratosis
`dermatitis, psoriasis,
`follicularis (Darier’s disease).
`
`“What medications do you take?” should also be
`asked. Very few adequately controlled double-
`blind studies have been done to determine the ef-
`
`
`
`Clinical Features
`
`History
`
`The patient’s history is occasionally forgotten in
`ophthalmology. Nowhere is it more important
`than in diagnosing dry eye syndromes. Several
`questions are so basic that they should be part of
`the routine examination. One such question is
`“What sorts of things bother your eyes?” Dry eye
`patients are exquisitely sensitive to drafts and
`winds. Often they willvolunteer information re-
`garding their intolerance to air conditioning or
`driving in the car with the windows rolled down.
`Reading is often difficult for dry eye sufferers.
`This probably occurs because the blink frequency
`decreases during tasks requiring concentration.
`As the blink frequency goes down, the length of
`time the eye is left exposed to the atmosphere
`may become longer than the tear breakup time
`(BUT) (discussed later), and so drying may in-
`crease. Patients often complain that nighttime or
`awakening is the worst part of their day. Sleep
`(like general anesthesia) decreases tear produc—
`tion. If the eye is already compromised with re-
`gard to tear flow, further reduction during sleep
`may be enough to produce nocturnal Symptoms. 1'
`This is especially true if concurrent blepharitis or
`lagophthalmos is present. Smoke is almost uni-
`versally intolerable to tear-deficient patients.
`Since smoke is actually a suspension of solid in
`air, the particulate bombardment of the ocular
`surface produces discomfort.
`“Do you have any skin diseases?” is a question
`that should always be asked. Although primary
`dermatologic illness is rarely the cause of a dry eye
`problem, looking for such illnesses often provides
`useful clues. Examples are numerous: sclero-
`derma, scurvy, thrombotic thrombocytopenic pur-
`pura, the facial rash in lupus (all these are seen
`in association with Sjogren’s syndrome), skin le-
`sions in pemphigoid, old scars from Stevens—John-
`son syndrome, and acne rosacea (associated with
`lipid abnormalities), to mention a few. An equally
`
`fects of systemic medications on tear flow. One
`study of birth control pills produced negative re-
`
`sults [14]. Chlorpheniramine was shown by Kof-
`fier and-'Lemp [33] to have a deleterious effect on
`tear production. Isotretinoin [15], hydrochloro—
`
`thiazide, and propranolol hydrochloride [32] have
`now been associated with decreased tear produfl‘
`tion. Eliciting other types of medication history:
`
`of help in learning about the patient’s gene"
`health.
`
`
`i
`
`"
`
`
`
`To ask about the patient’s other health prob—
`lems is perhaps so obvious as not to need me‘nJ
`tioning. It should be emphasized, however, that
`an entity such as -Sj(‘igren’s syndrome is truly a
`systemic disease that may involve any organ sys-
`tem, and that ophthalmologists see only a small
`part of an illness with protean manifestations.
`Symptoms desoribed or listed by the patient
`during the history taking are not particularly
`helpful in making the diagnosis of sicca. This is
`obviously due to the fact that there are no “dry
`7‘
`receptors” in the cornea. Instead, patients will
`usually complain of irritation, redness, or a vague '
`discomfort in the eye. Sometimes people will in— ,*
`' deed express the specific complaint of dryness, 1:,
`but this is not necessarily indicative of their un-
`derlying problem; it is merely another way to de-
`scribe discornfort. Often a patient with truly u .
`eyes will complain of tearing or excessive u
`tion in the eyes. These seemingly paradoxi
`complaints deserve a word of explanation.
`'
`i
`it is possible for the eye to get so dry that it
`comes irritated and tears reflexively, much as :
`eye might do if Suffering from a foreign body _
`abrasion. Second, as described in Chapter 13, _7
`eyes are particularly susceptible to excess mu
`precipitation. This can occasionally be such _
`annoying part of the symptoms that it will be .
`patient’s primary complaint (Plate 41).
`'
`
`i
`
`Physical Examination
`
`The objective physical examination is much u
`rewarding than the patient’s complaints in di
`
`
`
`

`

`Chapter 14 Clinical Diseases of the Tear Film
`
`461
`
`mg dry eye diseases. The following physical find,
`ings are discussed: filaments, meniscus height,
`meniscus floaters, mucous strands, and papillary
`conjunctivitis.
`Many factors have been implicated in the for-
`mation of filaments (Table 14—4), but by far the
`most common association is with dryness. Fila-
`ments (Plate 42) are short (usually < 2 mm long)
`“tails” that hang from the surface of the c0rnea.
`On sectioning a filament, one finds a periodic
`acid—Schiff (PASl—positive central core (mucin)
`surrounded by epithelium. Although the exact
`pathogenesis of filament formation is not known,
`the following represents a reasonable theory (Fig.
`14-3): When the cornea dries to a point that is in—
`compatible with a healthy epithelial layer, some
`surface cells will become desiccated and be shed.
`
`This creates a small pit on the corneal surface
`that is hydrophobic compared with the mucus-
`coated normal surface. Lipid-contaminated mu-
`cus will become attached to these pits by hydro-
`phobic bonding. Within a sh0rt time, surface
`epithelium will grow down these mucous cores,
`and a true filament will thus be born in_situ. Be—
`cause filaments are anchored to epithelial cells,
`pulling on them is very painful. Unfortunately,
`this is exactly what happens during blinking,
`with the resultant symptoms not unlike those
`produced by a foreign body.
`The normal human meniscus height is usually
`reported to be about 1 mm. In actual fact, normal
`subjects never have a meniscus height of that
`magnitude. Rather, a height of 0.2 to 0.3 mm is
`
`Table 14-4. Causes of corneal filaments
`
`Local
`
`Keratoconjunctivitis sicca
`Superior limbic keratoconjunctivitis
`Aerosol keratitis
`Beta radiation
`Herpes simplex viral infection
`Recurrent erosions
`
`Thygeson’s superficial punctate keratitis
`Cataract surgery
`-Neurotrophic and neurOparalylic keratitis
`Prolonged occlusion of the eyelids
`Retained foreign body beneath the upper lid
`Systemic
`Diabetes mellitus
`Psoriasis
`
`Ectodermal dysplasia
`Atopic dermatitis
`Osler—Weber—Rendujdisease
`
`'
`
`.
`
`'
`
`most common and will be found in about 85 per—
`cent of normal subjects [35].
`In a large population, no correlation was found
`between tear meniscus height and subsequent
`Schirmer test results [35]. In other words, people
`with a relatively high meniscus (0.4—0.6 mm) did
`not necessarily have a higher Schirmer test value.
`In a smaller study of nine patients with moderate
`to Severe dry eye (all had keratoconjunctivitis
`sicca or Sjogren’s syndrome confirmed by rose
`bengal staining and diminished Schirmer test
`values), I found that seven had a meniscus height
`of 0.1 mm and two had a meniscus height of 0.2
`mm (unpublished data, 1981). It seems then that
`in normal eyes the tear meniscus height is prob-
`ably subject to variables other than tear flow. Fac-
`‘tors such as the length of the lid, the location of
`the punctum,
`lid-globe apposition, and the dis-
`tance of the meibomian glands from the edge of
`the lid probably influence meniscus height. If tear
`flow is reduced beyond a certain level, this appar«
`ently is manifested by a reduced meniscus height.
`In this limited study, a meniscus height of only
`0.1 mm was present in 80 percent of the patients
`tested.
`
`Meniscus floaters are extremely common in
`dry eye patients. They can be seen as tiny bits of
`debris being carried along in the upper and lower
`tear menisci. Floaters probably have two origins.
`Some are dead epithelial cells that have fallen off
`the surface of the cornea, and some are small fi-
`brils of lipid-contaminated mucin. Although al-
`most always present in dry eyes, they are not
`pathognomom‘c, because patients with conjunc-
`tival
`infections or blepharitis may also show
`floaters.
`
`Mucous strands are actually strings of lipid-
`contaminated mucus that have rolled up and been
`pushed into the cul-de-sac by the shearing action
`of the lids. Although common in aque0us—defi-
`cient states, they can become rather spectacular
`in the mucin-deficient diseases (see'Plate 41). The
`
`i
`
`proposed dynamics of mucous strand formation
`are shown in Figure 14-4. If the aqueous layer of
`tears is thick enough to prevent diffusing lipid _
`from contaminating the mucous layer before a
`blink, or if mucin is available in excess to absorb
`the lipid molecules before a blink, then mucous
`strands will not become a problem. On the other
`hand, if mucin and excess lipid become intermin—
`gled, mucous strands may form.
`Papillary conjunctivitis is a rather n0nspecific
`reaction of the conjunctiva t0 irritation. It is com—
`monly seen in allergic eye disease, infections, and
`acne rosacea. Its presence in dry eye syndromes
`
`
`
`

`

`462
`
`
`
`
`
`Part ll Clinical Aspects
`
`
`
`Upper lid
`
`
`
`
`Mucous thread containing lipid
`moving downward
`
`
`Rolling up of mucus layer
`contaminated with lipid
`
`
`Dry 5P'3'l'—'b
`
`Lipid contaminated mucus layer
`Superficial lipid layer being
`compressed between the
`approximating lid edges
`
`
`
`
`
`
`' Cross section of mucous
`thread withrhigh lipid
`"" content in the lower
`fomix on the way to
`the puncta
`
`Fig. 14-4. Tentative mechanism for the formation of mu-
`Cous strands. As the tear film thins and breaks, sudaCe
`lipid may become apposed to the underlying mucin,
`forming lipid-mucin strands. (From F. J. Holly and M. A.
`Lemp, Tear physiology and dry eyes. Surv. Ophthalmol.
`22:69, 1977. With permission.)
`
`is mentionéd only to acknowledge its existence; it
`is of no value in making a diagnosis [39]. Staph-
`ylococcal blepharitis, which frequently accompa-
`nies a dry eye condition, can also result in punc-
`tate keratopathy and papillary hypertrophy of the
`conjunctiva.
`'
`
`_‘ Clinical Diagnostic Tests
`I I should openly confess at the start of this discus—
`sion that there is no reliable objective test to ren~
`der a firm diagnosis of dry eyes. Nevertheless,
`three tests are in common usage and are dis-
`cussed here. These are the rose bengal dye test,
`the measurement of tear BUT, and the Schirmer
`test.
`-
`r
`
`Fig. 14-3. A theory of filament formation. As a normal epi—
`thelial surface dries (A), some cells die and fall off, leaving
`a defect (B). Mucin may adhere to this high-energy pit (C),
`and eventual! epithelium may grow down over the mu—
`cin to form a illament (D). (From D. W. Lamberts, Dry Eye
`Syndromes. In C. 5. Foster [ed], Comeal and External
`Disease. Copyrighted by Year Book Medical Publishers,
`Inc, 1985. With permissiOn.)
`
`

`

`Chapter 14 Clinical Diseases of the Tear Film
`
`463
`
`Rose Bengal Stain
`Rose bengal, a red aniline dye, is a derivative of
`fluorescein but is different from fluorescein in
`
`several important ways. Rose bengal does not
`stain the precorneal tear film as does fluorescein.
`Instead, it seems to precipitate at the bottom of
`the meniscus. Unlike fluorescein, rose bengal
`does stain devitalized or abraded epithelial cells;
`this is probably due to rose bengal’s ability to
`stain cell nuclei and cell protoplasm. 0n the other
`hand, fluorescein is able to permeate through a
`disrupted epithelial layer and diffuse among the
`intercellular spaces. Rose bengal also stains mu-
`cus and filaments, whereas fluorescein stains
`only mucus.
`Rose bengal application (usually as a 1% solu-
`tion) is an extremely valuable test in the diagno-
`sis of sicca and deserves to be used more extent.-
`sively. It has only one disadvantage—irritation on
`instillation. The irritation seems to be directly re-
`lated to the amount of epithelial damage present
`on the corneal surface and, to some extent, the
`size of the drop. It is frequently possible to alle-
`viate some of this pain by drOpping the rose ben-
`gal onto the wooden end of a cotton-tip applicator
`and in turn touching the applicator to the inferior
`cul-‘de-sac. This decreases the amount of dye in-
`stilled in the eye. When rose bengal is used for
`evaluating dry eye patients, it is most helpful to
`divide each eye into three zones (medial, corneal,
`lateral) and reoord the amount of stain in each on
`a scale of 0 to 3 [73]. In this way, each eye could
`receive a maximum score of 9 if it stained maxi-
`
`mally in all three zones. A score of 3 or more for
`one eye is considered abnormal. Two false-posi~
`tives can be seen with rose bengal stain. A small
`amount of stain over the body of a pterygium or
`pinguecula is a common and normal finding. Also,
`if a Schirmer test has been performed before the
`use of rose bengal stain, the cenjunctiva will pick
`up the dye in the area of contact between the con-
`junctiva and the paper strip. It is important to re-
`member that in dry eye syndromes the pattern of
`'the stain, not merely its presence, is important.
`Anything that can damage the epithelium (infec-
`tions, trauma, toxic reactions) can cause rose ben-
`_. gal staining, but it is characteristic of sicca to pro-
`duce the pattern shown in Plate 43. This pattern,
`which is pathognomonic of keratoconjunctivitis
`sicca, consists of two triangles of stain on the
`conjunctiva with their bases on the limbus and
`in particularly severe cases, a connecting band
`across the cornea. This area corresponds to the
`exposed surface of the eye Within the palpebral
`fissure.
`‘
`
`_
`
`Norn [47] wrote a short but excellent text on
`examination of the external eye. He discussed the
`use of lissamine green in diagnosing dry eye.
`Norn stated that the dyeing quality of lissamine
`green is the same as that of rose bengal. Both so-
`lutions can be made in 1% concentration. It may
`be advantageous to use lissamine green rather
`than rose bengal because lissamine green causes
`no smarting. |
`
`.\
`
`Thar Breakup Time
`Tear BUT was originally described in 1969 by
`Norn [46], who referred to it as corneal wetting
`time. In this country, the concept of BUT was pop-
`ularized by Lemp and Hamill in 1973 [37]. Its
`measurement depends on the fact that given
`‘, enough time, the tear film will thin and eventu-
`ally rupture (even in normal eyes). The mecha-
`nism- of dry spot formation is discussed in Chap-
`ter 13. Its clinical measurement is accomplished
`as follows: A drop of fluoreScein is instilled in the
`eye. The patient is asked to blink two or three
`times to distribute the dye. The test is performed
`at the slit lamp by asking the patient to stare
`straight ahead and not blink. Without touching
`the patient’s eyelids, the examiner scans the cor-
`nea with the cobalt-blue light of the slit lamp,
`Watching for an area of tear film rupture mani-
`fested by a black island Within the green sea of
`fluorescein. The BUT is the time in seconds be-
`
`tween the last blink and the appearance of the
`dry spot. A normal BUT is considered to be 10 sec-
`onds or more. Several points are important when
`performing the test. First, the examiner must not
`touch the patient’s lids, nor should the patient ar-
`tificially elevate his or her lids. These maneuvers
`tend to expand the interpalpebral fissure and
`thus artificially shorten the BUT. Second, the
`areas of breakup must appear in a random pat-
`tern to be counted as tear film breakup. The rea-
`son for this is to avoid counting anepithelial ir—
`regularity or elevation (which will thin the tear
`film and cause a rapid breakup) as a representa—
`tive, random dry spot. Third,
`the solution in
`which the fluorescein is dissolved may theoreti- -
`cally play a role in BUT measm'ements. Some
`evidence suggests that the preserVatives in oph-
`thalmic irrigating solutions and even in the fluo-
`rescein paper strip itself may artificially lower
`the BUT (F. J. Holly, unpublished data, 1981).
`Some of these preservatives have detergent-like
`action and may break up the superficial lipid
`layer of the tear film, causing it to rupture pre-
`maturely. This may help to explain why BUT has
`fallen into some disrepute in recent years, since
`
`-
`
`
`
`
`
`

`

`464
`
`Part II Clinical Aspects .
`
`the nature of the fluorescein solution is a variable
`
`not usually controlled. It maybe better to use a
`nonpreserved type of fluorescein such as Fluore-
`soft (Holles Labs, Cohasset, MA) or one of the sev-
`eral brands of fluorescein for injection for BUT
`measurements. If one uses the latter, cauti0n
`must be taken to instill a very tiny drop (from the
`tip of a tuberculin syringe, for example), because
`these solutions are concentrated and burn on in-
`
`stillation. Because t0pical anesthetics also con— ‘
`tain preservatives that are surface-active and ca-
`pable of rupturing the tear film and adversely
`affecting the
`of the corneal surface [49],
`they should not be used for the test.
`A new method for measuring BUT was de-
`scribed in Chapter 13. I reiterate it briefly here.
`The test employs an instrument known as a to-
`poscope, which resembles a small visual field ap-
`paratus. By placing the patient’s head in the bowl,
`it is possible to reflect an optical grid pattern off
`the tear film. By observing this grid through a
`telescope, the observer can watch for a breakup to
`occur. A breakup is seen as a distortion of the n‘or-
`mally regular grid. The great advantage with this
`technique is that it is totally noninvasive. No
`fluorescein,
`topical anesthetic, or preServative
`needs to be placed in the tear film. In a study per-
`formed by the inventor of the toposcope (S. R.
`Tonge, personal communication, 1987),
`it was
`found that dry eye patients had shorter BUTs
`than did normal subjects, although all times were
`longer than previously described values using in-
`vasive tests.
`
`Schirmer Test
`
`In spite of its notorious variability, the Schirmer
`test remains the most commonly performed clini-
`cal test for sicca. For such a ubiquitous examina-
`tion, remarkably little basic science has been
`dune to explore the variabilities of the Schirmer
`test.
`It has been demonstrated in vitro that the vol-
`
`ume of water in milliliters applied to a paper strip
`has a linear relation to the length of wetting of
`the strip in millimeters. In vivo, the relationship
`is not so clear—cut. Figure 14-5 A presentsa graph
`of the wetting kinetics of Schirmer strips in nor-
`mal human volunteers. Figure 14-5 B is a com-
`panion graph of the rate of tear secretion plotted
`against time. The striking conclusion obtained
`from studying these curves is that tear production
`is extremely high in the first 2 minutes of the
`Schirmer test but levels off to a steady state at 4
`to 5 minutes. To be more explicit, these flow rates
`
`4r
`
`H D
`
`
` 'e’‘6’3Wettinglengthinmm
`rateinul/min 0
`Secretion
`
`0123456789101112
`Time in minutes
`
`A
`
`20
`
`15
`
`10
`
`0123456789101112
`Time in minutes
`
`B
`
`Fig. 14-5. A. When one examines the kinetics of a
`Schirmer test in vivo by plotting the wetting length versus
`time, one is struck by the rapid outflow of tears in the first
`3 or 4 minutes and by the leveling off to a steady state af-
`ter this time. B. If one plots rate of seCretion of tears (in
`vivo) versus time, one is again impressed by the precipi-
`tous fall in secretion

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket